logo
Select company
Select metric
15.72%Interest Expense Margin
VS
Market
10
Sector
15
Industry
23
History
16
$ 16.95Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information

Ticker

URGN

Company Name

UROGEN PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UROGEN PHARMA LTD - Interest Expense Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

URGN - Int. Exp. % Historical data
DateInterest ExpenseInterest Expense MarginRevenues
6/30/2025$ 14.81M15.72%$ 94.24M
3/31/2025$ 14.14M15.39%$ 91.87M
12/31/2024$ 12.52M13.85%$ 90.4M
9/30/2024$ 12.21M13.67%$ 89.36M
6/30/2024$ 13.31M15.66%$ 85.01M
3/31/2024$ 13.61M16.14%$ 84.3M
12/31/2023$ 14.71M17.79%$ 82.71M
9/30/2023$ 14.35M18.57%$ 77.28M
6/30/2023$ 13.23M18.24%$ 72.52M
3/31/2023$ 11.71M17.22%$ 67.98M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UROGEN PHARMA LTD's latest trailing twelve months (TTM) Int. Exp. % stands at -113.02%.
  • Over the past 5 years, UROGEN PHARMA LTD's average Int. Exp. % has been 3.78%.
  • The median Int. Exp. % for UROGEN PHARMA LTD during this period was 13.39%
  • UROGEN PHARMA LTD reached its highest Int. Exp. % over the past 5 years at 18.57%.
  • The lowest Int. Exp. % recorded by UROGEN PHARMA LTD in the same timeframe -113.02%

UROGEN PHARMA LTD's Int. Exp. % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. % Benchmarks
CompanyInt. Exp. %
NRIX : NURIX THERAPEUTICS INC 0%SNDX : SYNDAX PHARMACEUTICALS INC 26.53%GYRE : GYRE THERAPEUTICS INC 0%CRMD : CORMEDIX INC 0.03%NAGE : NIAGEN BIOSCIENCE INC 0%ZYME : ZYMEWORKS INC 0%PHAT : PHATHOM PHARMACEUTICALS INC 63.72%TBPH : THERAVANCE BIOPHARMA INC 3.34%WVE : WAVE LIFE SCIENCES LTD 0%KURA : KURA ONCOLOGY INC 1.91%

Definition of Interest Expense Margin

[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Int. Exp. / Revenues
(=) Int. Exp. %
Int. Exp. % for UROGEN PHARMA LTD is calculated as follows: Int. Exp. [ $ -4.33M ] / Revenues [ $ 3.83M ]
(=) Int. Exp. % [ -113.02% ]

URGN - Interest Expense Margin, Last 5 years

-113.02%

Minimum

Sep 30, 2020

18.57%

Maximum

Sep 30, 2023

3.78%

Average

13.39%

Median

Int. Exp. % Benchmark Analysis

The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
filtered constituents3.15K
min-4.94%
max8.49%
average1.63%
median0.79%
std2.2%